| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;73:819-824
© 2002 The Society of Thoracic Surgeons
a Cardiovascular Research, Starr Academic Center, St. Vincent Heart Institute, Department of Surgery, Oregon Health Sciences University, Portland, Oregon, USA
b Cardiovascular Research, Genentech, Inc, San Francisco, California, USA
c Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, P.R. China
Accepted for publication October 15, 2001.
* Address reprint requests to Dr He, Department of Surgery, The Chinese University of Hong Kong, Block B, 5A, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, P.R. China
e-mail: gwhe{at}cuhk.edu.hk
Background. Vascular endothelial growth factor (VEGF) has been shown to have potential to treat ischemic diseases. Moreover, its vasorelaxing or vasodilatory effect might be favorable for relieving graft spasm. In this study, we examined the vasorelaxing effects of recombinant VEGF in isolated human internal mammary artery (IMA) and compared the responses to acetylcholine and nitroglycerin.
Methods. Isometric tension of IMA ring segments was measured with an organ bath technique. With an optimal resting tension determined from its individual length-tension curve, precontraction was induced by 10-8 M U46619 and cumulative concentration-relaxation was measured by application of VEGF (10-12 to 10-8.5 M), acetylcholine (10-10 to 10-5 M), and then nitroglycerin (10-4.5 M).
Results. Vascular endothelial growth factor induced concentration-dependent relaxation (EC50: -9.89 ± 0.05 log M; Emax: 63.2% ± 7.3%) in IMA with intact endothelium. The relaxant responses to VEGF were significantly attenuated by pretreatment with N
-nitro-L-arginine (L-NNA) alone and indomethacin + L-NNA, and totally abolished by removal of the endothelium or pretreatment with indomethacin + L-NNA + oxyhemoglobin. Internal mammary arteries became more sensitive to VEGF in the presence of indomethacin alone. However, acetylcholine-induced relaxation was not abolished by treatment with indomethacin + L-NNA + oxyhemoglobin (Emax: 16.9% ± 2.7%). The endothelium-independent relaxations induced by nitroglycerin were also significantly inhibited by administration of oxyhemoglobin.
Conclusions. The results demonstrate that VEGF-induced endothelium-dependent relaxation in the human IMA is mainly due to nitric oxide release. Although the vasorelaxing effect is not the primary advantage of this drug when it is used for angiogenesis, such effect may be advantageous in patients who also need a coronary artery bypass operation.
Related Article
Ann. Thorac. Surg. 2002 73: 824.
This article has been cited by other articles:
|
|
 |
|
  G.-W. He, M.-H. Liu, Q. Yang, A. Furnary, and A. P.C. Yim Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery Ann. Thorac. Surg., November 1, 2007; 84(5): 1522 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Husain, M. Vazquez-Ortiz, and J. Lalla Down regulation of aortic nitric oxide and antioxidant systems in chronic alcohol-induced hypertension in rats Human and Experimental Toxicology, May 1, 2007; 26(5): 427 - 434. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Mannheim, D. Versari, E. Daghini, M. Gossl, O. Galili, A. Chade, V. S. Rajkumar, E. L. Ritman, L. O. Lerman, and A. Lerman Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2449 - H2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jacobs, D. Zhu, S. Gruenloh, B. Lopez, and M. Medhora VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L369 - L377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ashrafpour, N. Huang, P. C. Neligan, C. R. Forrest, P. D. Addison, M. A. Moses, R. H. Levine, and C. Y. Pang Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H946 - H954. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
